Coffee Sipping Big Board Stocks

[timhyma]

Exact Sciences Corp. (EXAS) on Tuesday reported a loss of $47.5 million in its first quarter.

On a per-share basis, the Madison, Wisconsin-based company said it had a loss of 49 cents.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 54 cents per share.

The molecular diagnostics company posted revenue of $14.8 million in the period, also beating Street forecasts. Six analysts surveyed by Zacks expected $14.7 million.

Exact Sciences shares have fallen 24 percent since the beginning of the year. The stock has declined 67 percent in the last 12 mont